NEW YORK (GenomeWeb News) – Meridian Bioscience today reported second-quarter revenue growth of 16 percent with double-digit growth for its life science and US diagnostics business.

The Cincinnati-based diagnostics firm reported total revenues of $47.4 million for the three-month period ended March 31, up 16 percent from $41.1 million for the first quarter of 2011. It beat the consensus Wall Street estimate of $44.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.